Introduction Coronary Artery Disease (CAD) remains a leading cause of morbidity and mortality worldwide, presenting a formidable challenge to global healthcare systems. While current treatments have significantly improved patient outcomes, the persistent burden of CAD necessitates continuous innovation. The landscape of CAD treatment is on the cusp of a revolutionary transformation, driven by an accelerating […]